The United States Patent and Trademark Office (USPTO) has now
announced how it will exercise its authority under the Coronavirus
Aid, Relief, and Economic Security Act (CARES Act) to extend
certain statutory deadlines. Unlike other patent offices that have
taken an across-the-board approach and extended all deadlines
falling within a certain window to a later date, the USPTO is
taking a case-by-case approach that applies only to those
“personally affected by the COVID-19 outbreak.”
Patent Office Extensions of Time Under the CARES Act
As reported in this
article, Section 12004 of the CARES Act granted the USPTO
temporary authority to extend statutory deadlines. The
USPTO’s announcement on March 31, 2020, explains how
the agency is exercising that authority for patent-related
deadlines. Three things practitioners and stakeholders should note
are (1) only certain deadlines are eligible for this relief, (2)
only certain parties are eligible to claim this relief, and